The efficacy of abiraterone acetate in treating Taiwanese chemo-refractory metastatic castration-resistant prostate cancer patients

Objective: To evaluate the efficacy of abiraterone acetate in combination with prednisolone in Taiwanese men with metastatic castrate-resistant prostate cancer (mCRPC) who failed docetaxel-based chemotherapy. Materials and methods: In this single-arm, open label study, 30 mCRPC patients with prostat...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Tony Wu, Hsi Chin Wu, Yen Chuan Ou, See-Tong Pang, Yeong-Shiau Pu, Yen-Hwa Chang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wolters Kluwer Health/LWW 2016-12-01
Sarja:	Urological Science
Aiheet:	abiraterone acetate docetaxel metastatic castration-resistant prostate cancer prednisolone prostate-specific antigen
Linkit:	http://www.sciencedirect.com/science/article/pii/S1879522615004455
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!